BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260409
DTEND;VALUE=DATE:20260410
DTSTAMP:20260410T123228
CREATED:20260213T105034Z
LAST-MODIFIED:20260213T105034Z
UID:10002106-1775692800-1775779199@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Dementia Research Network Ireland ECR Day
DESCRIPTION:DRNI’s annual Early Career Researcher Day is back! DRNI ECR Day 2026 is taking place in the Human Biology Building\, University of Galway\, on Thursday\, 09 April 2026. \nThis is an in-person event\, and is a free event and open to all! \nDRNI ECR Day is a great opportunity for ECRs from across the island of Ireland to present their research\, meet their peers\, network with other researchers\, and become more familiar with the dementia research landscape in Ireland. It is open to all disciplines\, and will be an in-person event. \nTo register to attend\, or to apply to present your research\, please go to: DRNI ECR Day 2026 Registration Form – Fill out form \nPresentation applications \nDRNI welcomes applications for oral and poster presentations. All application abstracts should be no longer than 150 words\, and use headings such as Introduction\, Methods\, Results\, Conclusion. All applications must be made under one of three themes: \n\nTheme 1 – Dementia risk reduction and prevention\nTheme 2 – The lived experience of dementia and quality of life\nTheme 3 – Therapeutics and diagnostic pathways\n\nAs part of DRNI’s commitment to Person and Public Involvement (PPI) in research\, we will be awarding a prize for PPI engagement at the event. If you would like to be considered for this prize\, there is additional space on the registration form to outline how your research incorporates PPI (world limit 75 words). \nThe deadline for abstract submissions is Friday\, 27th February 2026. \nThere are a limited number of travel bursaries available to help with travel costs – if you are interested\, please tick the relevant box in the registration form. \nIf you have any questions about this in-person event\, please contact Vanessa: mooreva@tcd.ie. \n 
URL:https://www.dementiaresearcher.nihr.ac.uk/event/dementia-research-network-ireland-ecr-day/
LOCATION:University of Galway\, University Rd\, Galway\, Ireland
CATEGORIES:Training
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/08/Dementia-Research-Network-Ireland-logo.png
ORGANIZER;CN="Dementia Research Network Ireland":MAILTO:mooreva@tcd.ie
GEO:53.276035;-9.0595869
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=University of Galway University Rd Galway Ireland;X-APPLE-RADIUS=500;X-TITLE=University Rd:geo:-9.0595869,53.276035
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260409
DTEND;VALUE=DATE:20260411
DTSTAMP:20260410T123228
CREATED:20260113T215051Z
LAST-MODIFIED:20260113T215051Z
UID:10002046-1775692800-1775865599@www.dementiaresearcher.nihr.ac.uk
SUMMARY:DSAD - ASAD Conference
DESCRIPTION:This is the third edition of this groundbreaking conference\, which aims to foster collaboration and knowledge exchange between the fields of Down Syndrome associated Alzheimer disease (DSAD) and autosomal dominant AD (ADAD). \nThe event will feature research findings\, clinical trials\, and more\, with an inclusive approach to diversity\, representation\, and accessibility. \n\n\n\n\nThis conference will be a seminal event in advancing the understanding and treatment of Alzheimer’s disease (AD)\, particularly by bridging the fields of Down Syndrome Alzheimer’s disease (DSAD) and Autosomal Dominant Alzheimer’s disease (ADAD). It emphasizes collaboration\, ethical considerations\, and inclusivity\, fostering a unified approach to tackling both conditions. \nA key focus of the conference will be creating lasting networks and collaborations\, ensuring that the dialogue and progress continue well beyond the event itself. Building on the success of the previous conferences\, which attracted close to 200 in-person attendees and many more online from over 20 countries\, this third conference aims to expand on that momentum. In addition to the strong support from the DSAD research community\, we have renowned international ADAD speakers\, with outreach through the DIAN network. The event will promote cross-fertilization of ideas\, highlighting the potential for shared insights between these genetically determined forms of AD. This is particularly timely as we now have several ongoing drug development projects in both DSAD and ADAD\, with more planned. The exchange of ideas between researchers in these areas is crucial for maximizing the impact of therapeutic strategies. \nIn conclusion\, the conference will cultivate a collaborative\, diverse\, and inclusive environment to advance research in DSAD and ADAD. The collective expertise of the organizing and scientific committee\, combined with support from key stakeholders in Alzheimer’s research\, will ensure a successful and impactful event. This gathering represents a significant step forward in global AD research\, providing a dynamic platform that fosters connections\, innovation\, and progress in understanding and treating these intertwined conditions. \nAttendees\, Inclusivity & Collaboration Strategy to promote Diversity\, Equity\, and Inclusion: \n\nIntended Audience: Targeting a diverse group of students\, researchers\, clinicians\, experts\, policy-makers\, and other stakeholders interested in genetically determined AD.\nSelection Process & Inclusivity: Striving for a balanced and diverse program\, selecting top communications from a wide range of contributors.\nGender Balance & Ethnic and Geographical Diversity: Aiming for balanced representation of gender among speakers\, moderators\, and attendees. Actively promoting participation from various ethnic backgrounds and geographical regions.\nEarly and Senior Researchers: Ensuring a mix of early-career and senior researchers in all sessions.\nSupport for Attendees with Families: Provision of daycare services to support those with childcare responsibilities and enable their attendance.\n\nFind out More
URL:https://www.dementiaresearcher.nihr.ac.uk/event/dsad-asad-conference/
LOCATION:Modernist Hospital of Sant Pau\, Sant Antoni Maria Claret Street\, 16\, Barcelona\, Spain
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/DSAD-ADAD.png
GEO:41.4031935;2.1639358
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Modernist Hospital of Sant Pau Sant Antoni Maria Claret Street 16 Barcelona Spain;X-APPLE-RADIUS=500;X-TITLE=Sant Antoni Maria Claret Street\, 16:geo:2.1639358,41.4031935
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T020000
DTEND;TZID=Europe/London:20260409T150000
DTSTAMP:20260410T123228
CREATED:20260313T201037Z
LAST-MODIFIED:20260310T201401Z
UID:10002148-1775700000-1775746800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Perspectives on FTD and Care in India
DESCRIPTION:Join the ISTAART Frontotemporal Dementia and Related Disorders Professional Interest Area (PIAs) for a webinar\, Perspectives on FTD and Care in India. This webinar will present a clinically grounded overview of FTD in India\, focusing on how the disease is currently recognized\, characterized and managed across different clinical settings. \nSign up here and join us on Thursday\, April 9\, 2026 at 8 a.m. C.T.  \nModerator: \n\nSwetha Mohan\, Ph.D.; Madrone Biosciences LLC\, United States\n\nSpeakers: \n\nAtri Chatterjee\, M.D.\, Vardhman Mahavir Medical College and Safdarjung Hospital\, India\nRatnavalli Ellajosyula\, M.D.; Manipal Hospital and Annasawmy Mudaliar Hospital\, India\nSoumya Hegde\, MBBS\, DPM\, MRCPych\, CCT; Memory Matters\, India\nRamshekhar N. Menon\, M.D.\, DNB; DM; Sree Chitra Tirunal Institute for Medical Sciences and Technology\, Trivandrum\, India\n\n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/perspectives-on-ftd-and-care-in-india/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T140000
DTEND;TZID=Europe/London:20260409T153000
DTSTAMP:20260410T123228
CREATED:20260327T120904Z
LAST-MODIFIED:20260327T120904Z
UID:10002168-1775743200-1775748600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Biomarkers: health system implementation
DESCRIPTION:WDC virtual dialogue \n\n\n\n\nRapid scientific progress in plasma biomarkers is transforming the possibilities for earlier and more accessible diagnosis of Alzheimer’s disease. Yet translating these advances into routine clinical practice presents significant challenges\, including demonstrating clinical utility\, integrating testing into existing care pathways\, and ensuring that health systems are prepared for wider use. \nChaired by Dr Fiona Carragher\, Chief Policy and Research Officer at the Alzheimer’s Association\, the meeting will feature opening presentations from Professor Vanessa Raymont of the University of Oxford and Professor Jeff Burns of the University of Kansas\, followed by a round-table discussion. Additional speakers will be announced. The dialogue will explore how emerging biomarker technologies can move from research settings into real-world health systems and what evidence\, infrastructure\, and policy changes are required to support their effective adoption. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/biomarkers-health-system-implementation/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2020/12/World-Dementia-Council.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T163000
DTEND;TZID=Europe/London:20260409T230000
DTSTAMP:20260410T123228
CREATED:20260401T144837Z
LAST-MODIFIED:20260401T144837Z
UID:10002176-1775752200-1775775600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Synuclein Biomarkers & Neuropathology Summit 2026
DESCRIPTION:Join co-chairs\, Dr. Robert Rissman and Dr Nicholas Ashton for a focused scientific summit bringing together leading investigators\, clinicians\, and translational researchers to advance the future of synuclein biomarker development. This meeting will spotlight emerging hypotheses\, active research programs\, and key challenges limiting antemortem detection across Alzheimer’s disease–related dementias and movement disorders. \n\n\nThrough expert-led discussions\, the summit aims to deepen understanding of synuclein pathology\, ongoing therapeutic trials\, and biomarker strategies to help accelerate earlier\, more accurate detection. \n\n\nagenda\n\n\nThursday\, April 9\n9:00 am-4:30 pm: Main Session \nKEYNOTE PRESENTATION\nMajor Hypotheses in Synuclein Research Alzheimers Disease & Parkinsons Disease\nLea Grinberg\, MD\, PhD – Mayo Clinic \nSession 1 (panel discussion): Clinical Standards for Synuclein\nModerator: Robert Rissman\, PhD – Epstein Family ATRI\, USC\nPanelists:\nPaul Aisen\, MD – Epstein Family ATRI\, USC\nAmy Kind\, MD\, PhD – University of Wisconsin\nJames Leverenz\, MD – University of Washington\nAhmad Sajjadi\, MD – UC Irvine School of Medicine\n\nSession 2: Synuclein (detecting and treating)\nModerator: Nicholas Ashton\, PhD – Banner Health\nSpeakers:\nBrian Spencer\, PhD – Epstein Family ATRI\, USC\nPam J. Mclean\, PhD – Mayo Clinic\nDuygu Tosun-Turgut\, PhD – UCSF\nHartmuth Kolb\, PhD – Enigma Biomedical USA\n\nSession 3: Synuclein Proteomics\nModerator: Steve Williams\, MD\, PhD – Alamar Biosciences\nSpeakers:\nCarlos Cruchaga\, PhD – Washington University School of Medicine\nNicholas Ashton\, PhD – Banner Health\nNicolas T. Seyfried\, PhD – Emory University School of Medicine\n\nSession 4 (panel discussion): Biomarker Therapeutics\nModerator: Sterling Johnson\, PhD – University of Wisconsin\nPanelists:\nJoel Mathews\, PhD – Ionis\nSteve Williams\, MD\, PhD – Alamar Biosciences\nLuis Concha\, PhD – Amprion\nCharbel Moussa\, MBBS\, PhD – Georgetown University Medical Center\n\nSession 5 (panel discussion): Future Directions\nModerator: Nicholas Ashton & Robert Rissman\nPanelists:\nLea Grinberg\, MD\, PhD – Mayo Clinic\nSterling Johnson\, PhD – University of Wisconsin\nSusan Landau\, PhD – UC Berkeley\nSteve Williams\, MD\, PhD – Alamar Biosciences\n \n4:30 pm: Closing Remarks & Adjourn \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/synuclein-biomarkers-neuropathology-summit-2026/
LOCATION:Online\, United Kingdom
CATEGORIES:Summit
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/09/Alamar-Biosciences-virtual-ARGOnaut-Club-Voyager-Summit-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T190000
DTEND;TZID=Europe/London:20260409T200000
DTSTAMP:20260410T123228
CREATED:20260313T150026Z
LAST-MODIFIED:20260311T153926Z
UID:10002149-1775761200-1775764800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:ISTAART Neuroscience Mentoring Club
DESCRIPTION:The ISTAART Alliance of Women Alzheimer’s Researchers (AWARE) and Immunity and Neurodegeneration PIAs invite you to join the next ISTAART Neuroscience Mentoring Club.  \nISTAART Neuroscience Mentoring Clubs are informal virtual meetings that aim to create a relaxed\, confidential space for junior and senior PIA members to connect\, exchange ideas and share perspectives. These sessions aim to stimulate collaboration\, foster mentorship and facilitate interaction between members from all backgrounds and career stages. \nISTAART Neuroscience Mentoring Clubs are not recorded\, allowing for open dialogue and feedback. \nSign up here to join us on Thursday\, April 9\, 2026\, at 1 p.m. C.T. \nSpeaker: \n\nColleen Rosemarie Zaccard\, Ph.D.\, Northwestern University\n\nModerator: \n\nAngela Gomez Arboledas\, Ph.D.\, University of California\, Irvine\n\n\nRegister\n  \nIf you are not a member of one of these PIAs\, we invite you to join today to stay informed. See this guide for details on joining a PIA. 
URL:https://www.dementiaresearcher.nihr.ac.uk/event/istaart-neuroscience-mentoring-club-2/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
END:VCALENDAR